Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr;56(4):395-405.
doi: 10.1007/s00535-021-01777-0. Epub 2021 Mar 19.

A novel risk factor panel predicts early recurrence in resected pancreatic neuroendocrine tumors

Wen-Quan Wang #  1   2   3   4 , Wu-Hu Zhang #  1   2   3   4 , He-Li Gao #  1   2   3   4 , Dan Huang  2   5 , Hua-Xiang Xu  1   2   3   4 , Shuo Li  1   2   3   4 , Tian-Jiao Li  1   2   3   4 , Shuai-Shuai Xu  1   2   3   4 , Hao Li  1   2   3   4 , Jiang Long  1   2   3   4 , Long-Yun Ye  1   2   3   4 , Chun-Tao Wu  1   2   3   4 , Xuan Han  1   2   3   4 , Xiao-Hong Wang  2   6 , Liang Liu  7   8   9   10 , Xian-Jun Yu  11   12   13   14
Affiliations

A novel risk factor panel predicts early recurrence in resected pancreatic neuroendocrine tumors

Wen-Quan Wang et al. J Gastroenterol. 2021 Apr.

Abstract

Background: Pancreatic neuroendocrine tumors (PanNETs) are indolent pancreatic tumors derived from neuroendocrine cells in pancreatic islets. To date, reliable predictors for identifying patients at high risk for recurrence after curative cancer resection are lacking. We aimed to determine independent predictors for high-risk PanNETs and patient outcomes after surgery.

Methods: We analyzed relevant clinicopathological parameters in 319 consecutive patients of derivation cohort 1 and 106 patients of validation cohort 2 who underwent pancreatectomy and were diagnosed with PanNETs. Association of tumor characteristics with recurrence-free survival (RFS) and overall survival (OS) was evaluated using Cox regression.

Results: PanNET grade 3 (G3), pancreatic duct dilatation, and perineural invasion were independent prognostic factors for RFS and were significantly associated with early recurrence (within 1.5 years) of PanNETs after curative resection (P = 0.019, P < 0.001, and P < 0.001, respectively). Using these factors, we established a novel risk factor panel (R-panel), which predicted early recurrence (P < 0.001, HR = 15.02, 95% CI 5.76-39.19). Predictive accuracy of this R-panel was favorable, with a C-index of 0.853, higher than AJCC TNM staging (0.713). We further built an integrated staging system combining R-panel scoring and TNM staging, which improved predictive probability of TNM staging. Finally, we showed that adjuvant therapy with long-acting somatostatin analogs (SSAs) significantly reduced postoperative recurrence (P < 0.001) and prolonged long-term survival (P = 0.021) in patients with the above risk factors.

Conclusion: We identified a novel risk factor panel, which includes PanNET G3, pancreatic duct dilatation, and perineural invasion; this panel predicted early recurrence of PanNETs after curative resection. Patients with these risk factors can benefit from adjuvant therapy with SSAs.

Keywords: Grading; Pancreatic duct dilatation; Pancreatic neuroendocrine tumors (PanNETs); Perineural invasion; Predictors.

PubMed Disclaimer

References

    1. Rindi G, Klimstra DS, Abedi-Ardekani B, et al. A common classification framework for neuroendocrine neoplasms: an international agency for research on cancer (IARC) and world health organization (WHO) expert consensus proposal. Mod Pathol. 2018;31:1770–86. - DOI
    1. Lloyd RV, Osamura R, Kloppel G, et al. WHO classification of tumours of endocrine organs. Lyon, France: IARC Press; 2017.
    1. Cives M, Strosberg JR. Gastroenteropancreatic neuroendocrine tumors. CA Cancer J Clin. 2018;68:471–87. - DOI
    1. Partelli S, Bartsch DK, Capdevila J, et al. ENETS consensus guidelines for standard of care in neuroendocrine tumours: surgery for small intestinal and pancreatic neuroendocrine tumours. Neuroendocrinology. 2017;105:255–65. - DOI
    1. Luo G, Javed A, Strosberg JR, et al. Modified staging classification for pancreatic neuroendocrine tumors on the basis of the American joint committee on cancer and european neuroendocrine tumor society systems. J Clin Oncol. 2017;35:274–80. - DOI

LinkOut - more resources